Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Actinobacteria |
Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Ranitidine |
Click to Show/Hide the Detail |
Drug ID |
DR1393
Drug Info
|
Interaction Mechanism |
Human Dimethylaniline oxidase 5 (FMO5) and Bifidobacterium breve co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Bacteroidetes |
Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Ranitidine |
Click to Show/Hide the Detail |
Drug ID |
DR1393
Drug Info
|
Interaction Mechanism |
Human Dimethylaniline oxidase 5 (FMO5) and Bacteroides fragilis co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Ranitidine |
Click to Show/Hide the Detail |
Drug ID |
DR1393
Drug Info
|
Interaction Mechanism |
Human Dimethylaniline oxidase 5 (FMO5) and Parabacteroides johnsonii co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Firmicutes |
Enterococcus faecalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Ranitidine |
Click to Show/Hide the Detail |
Drug ID |
DR1393
Drug Info
|
Interaction Mechanism |
Human Dimethylaniline oxidase 5 (FMO5) and Enterococcus faecalis co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Hungatella hathewayi (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Ranitidine |
Click to Show/Hide the Detail |
Drug ID |
DR1393
Drug Info
|
Interaction Mechanism |
Human Dimethylaniline oxidase 5 (FMO5) and Hungatella hathewayi co-metabolize the drug Ranitidine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
|
|
|
|
|
|